L. Lescale-Matys

409 total citations
9 papers, 349 citations indexed

About

L. Lescale-Matys is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, L. Lescale-Matys has authored 9 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 2 papers in Oncology and 1 paper in Surgery. Recurrent topics in L. Lescale-Matys's work include Ion Transport and Channel Regulation (5 papers), Ion channel regulation and function (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). L. Lescale-Matys is often cited by papers focused on Ion Transport and Channel Regulation (5 papers), Ion channel regulation and function (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). L. Lescale-Matys collaborates with scholars based in United States, United Kingdom and Japan. L. Lescale-Matys's co-authors include Alicia A. McDonough, Daun Putnam, Ernest M. Wright, Soraya P. Shirazi‐Beechey, Tom C. Freeman, D. Scott, Jane Dyer, C. B. Hensley, K. K. Azuma and Clara E. Magyar and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Biochemical Journal.

In The Last Decade

L. Lescale-Matys

9 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Lescale-Matys United States 8 211 81 71 54 45 9 349
Corinna Helmle‐Kolb Switzerland 15 457 2.2× 50 0.6× 101 1.4× 67 1.2× 48 1.1× 24 563
M. Tosco Italy 14 291 1.4× 37 0.5× 99 1.4× 114 2.1× 82 1.8× 53 507
Sylvain Molon-Noblot France 11 135 0.6× 83 1.0× 43 0.6× 67 1.2× 14 0.3× 27 371
Kamiar Mohammadi France 6 353 1.7× 42 0.5× 43 0.6× 52 1.0× 28 0.6× 7 449
Michael Hoefer United States 10 137 0.6× 135 1.7× 77 1.1× 24 0.4× 19 0.4× 17 479
Clara Ledoussal United States 5 222 1.1× 29 0.4× 58 0.8× 45 0.8× 33 0.7× 7 318
M. L. Calonge Spain 14 247 1.2× 29 0.4× 40 0.6× 109 2.0× 39 0.9× 35 494
Erwann Philippe France 11 158 0.7× 56 0.7× 96 1.4× 106 2.0× 55 1.2× 18 357
Masatoshi Hazama Japan 10 153 0.7× 100 1.2× 79 1.1× 26 0.5× 19 0.4× 17 360
Susan J. DeRemer United States 11 86 0.4× 102 1.3× 23 0.3× 109 2.0× 43 1.0× 16 452

Countries citing papers authored by L. Lescale-Matys

Since Specialization
Citations

This map shows the geographic impact of L. Lescale-Matys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Lescale-Matys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Lescale-Matys more than expected).

Fields of papers citing papers by L. Lescale-Matys

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Lescale-Matys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Lescale-Matys. The network helps show where L. Lescale-Matys may publish in the future.

Co-authorship network of co-authors of L. Lescale-Matys

This figure shows the co-authorship network connecting the top 25 collaborators of L. Lescale-Matys. A scholar is included among the top collaborators of L. Lescale-Matys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Lescale-Matys. L. Lescale-Matys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Dezube, Bruce J., Razelle Kurzrock, Joseph P. Eder, et al.. (2007). Interim results of a phase I trial with a novel orally administered synthetic triterpenoid RTA 402 (CDDO-Me) in patients with solid tumors and lymphoid malignancies. Journal of Clinical Oncology. 25(18_suppl). 14101–14101. 7 indexed citations
2.
Azuma, K. K., Daniel F. Balkovetz, Clara E. Magyar, et al.. (1996). Renal Na+/H+ exchanger isoforms and their regulation by thyroid hormone. American Journal of Physiology-Cell Physiology. 270(2). C585–C592. 60 indexed citations
3.
Lescale-Matys, L., Jane Dyer, D. Scott, et al.. (1993). Regulation of the ovine intestinal Na+/glucose co-transporter (SGLT1) is dissociated from mRNA abundance. Biochemical Journal. 291(2). 435–440. 104 indexed citations
4.
Lescale-Matys, L., Daun Putnam, & Alicia A. McDonough. (1993). Na(+)-K(+)-ATPase alpha 1- and beta 1-subunit degradation: evidence for multiple subunit specific rates. American Journal of Physiology-Cell Physiology. 264(3). C583–C590. 60 indexed citations
5.
Lescale-Matys, L., Daun Putnam, & Alicia A. McDonough. (1993). Surplus Na+ pumps: how low-K(+)-incubated LLC-PK1 cells respond to K+ restoration. American Journal of Physiology-Cell Physiology. 265(4). C887–C892. 10 indexed citations
6.
McDonough, Alicia A., L. Lescale-Matys, Ming‐Jer Tang, et al.. (1992). Physiologic Rationale for Multiple Sodium Pump Isoforms. Annals of the New York Academy of Sciences. 671(1). 156–169. 23 indexed citations
7.
Wright, Ernest M., E. Turk, Klaus Häger, et al.. (1992). The Na+/glucose cotransporter (SGLT1).. PubMed. 607. 201–7. 19 indexed citations
8.
McDonough, Alicia A., Ming‐Jer Tang, & L. Lescale-Matys. (1990). Ionic regulation of the biosynthesis of NaK-ATPase subunits.. PubMed. 10(4). 400–9. 11 indexed citations
9.
Lescale-Matys, L., et al.. (1990). Low K+ increases Na,K-ATPase abundance in LLC-PK1/Cl4 cells by differentially increasing beta, and not alpha, subunit mRNA.. Journal of Biological Chemistry. 265(29). 17935–17940. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026